awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q24241813-35E91B0D-A774-4D0B-9CA7-4081FA1D219B
Q24241813-35E91B0D-A774-4D0B-9CA7-4081FA1D219B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24241813-35E91B0D-A774-4D0B-9CA7-4081FA1D219B
Anti-angiogenic therapies for metastatic colorectal cancer
P2860
Q24241813-35E91B0D-A774-4D0B-9CA7-4081FA1D219B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24241813-35E91B0D-A774-4D0B-9CA7-4081FA1D219B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5cfb78b46036b2affca9ff84f8a089d2b85224a5
P2860
A phase III randomized, open-label, controlled trial of chemotherapy and bevacizumab with or without panitumumab in the first-line treatment of patients with metastatic colorectal cancer.